Acylact - instructions for use, doses, side effects, contraindications

The preparation is a microbial mass of living, antagonistically active lactobacilli of acidophilic strains Lactobacillus acidophilus 100аш, NK₁, K₃W₂₄, lyophilized in a culture medium supplemented with sucrose-gelatin-lactic environment. Composition: a single dose of the drug contains: at least 10⁷live lactobacillus acidophilus, sucrose - 8%; gelatin - 1%; milk fat-free - 20%. Crystalline or porous mass of beige or whitish-gray color with a specific odor.

Pharmacotherapeutic group:MIBP-eubiotic

ATX: & nbsp

G.01.A.X Other antiseptics and antimicrobials for the treatment of gynecological diseases

G.01.A.X.14 Lactobacilli

Pharmacodynamics:Live microbial cells of lactobacillus acidophilic have a high antagonistic activity against a wide range of pathogenic and opportunistic microorganisms, which determines the corrective effect of the drug in cases of bacteriocenosis disorders in the oral cavity, intestine and female genitalia.

Indications:

Purpose: treatment of diseases of the oral cavity, gastrointestinal tract and female genitalia, accompanied by a violation of normal microflora. The drug is used for adults and children, regardless of age.

Indications for use:

In diseases of the oral cavity:

- Inflammatory diseases of the oral mucosa (glossitis, aphthous stomatitis, ulcerative-necrotic gingivitis);

- pathological changes in the oral mucosa, accompanying systemic diseases (lichen planus, multiforme exudative erythema, Shagren's disease);

- other oral diseases associated with dysbacteriosis (galvanism, multiple tooth decay, caries, periodontitis),preparation for planned maxillofacial operations in order to prevent purulent-inflammatory complications.

In diseases of the gastrointestinal tract:

- acute intestinal infections, food-borne diseases caused by opportunistic microorganisms or unidentified etiology, rotavirus gastroenteritis;

- prolonged intestinal disorders, especially in young children;

- protracted and chronic colitis and enterocolitis of infectious and non-infectious etiology, accompanied by a disturbance of microflora;

- moderate and mild form of ulcerative colitis in adults;

- weakened often ill children and adults with dysbacteriosis, including those accompanied by immunodeficiency;

- complex therapy of atopic dermatitis in children with the phenomenon of intestinal dysbacteriosis.

In diseases of the female sexual sphere:

- colpitis (except for cases of gonococcal, trichomonas and candidiasis) - acylact is prescribed as an independent remedy after the end of the course of antibacterial therapy;

- vaginal dysbiosis, accompanying the inflammatory processes of the cervix, body and appendages of the uterus - after the end of the course of antibiotic therapy;

- preparation for planned gynecological operations for the purpose of preventing postoperative infectious complications;

- prenatal preparation of pregnant at-risk groups for purulent development-septic complications.

Contraindications:It is not recommended for vulvovaginal candidiasis.

Pregnancy and lactation:Lactobacilli are representatives of normal human microflora, therefore, preparations made on their basis, can be used in pregnancy and lactation.

Dosing and Administration:

Depending on the disease, the acylactate is administered orally, topically and intravaginally.

The contents of the vial to dissolve boiled water at room temperature at the rate of 5 ml (teaspoon) of water per 1 dose of the drug.

Dissolve as follows: pour the required amount of water in a glass (according to the number of doses indicated on the vial); open the bottle by removing the cap and stopper; from the glass to transfer a small amount of water into the bottle; after dissolution (the drug dissolves no more than 5 minutes with the formation of a homogeneous suspension of beige or whitish-gray color), transfer the contents of the vial into the same beaker and mix.One teaspoon of the drug dissolved in this way is 1 dose. Dissolved drug is not subject to storage.

The daily dose and duration of treatment is determined by the doctor depending on the clinical form of the disease and the severity of dysbiosis.

In diseases of the oral mucosa, acylactate is used after a meal in the form of an aqueous rinse suspension.

When glossitis is prescribed for 5 doses 2-3 times a day, the course of treatment is 14-15 days. With recurrent aphthous stomatitis and ulcerative-necrotic gingivitis, the treatment is carried out by the same scheme with two courses with a break of 7 days.

In case of pathological processes in the oral cavity caused by systemic diseases (lichen planus lichen multiforme exudative erythema, Schagren's disease), appoint 10 doses per day in 4 divided doses with two courses of 14-15 days each with a break of 7 days.

Patients with intestinal disorders before the age of 6 months are prescribed 5 doses per day, preferably in 2 divided doses, children older than 6 months and adults - 5 doses 2-3 times a day for 30-40 minutes before meals.

In acute inflammatory processes of the intestine, the course of treatment is 7-8 days, with prolonged and recurrent forms of the disease - 14-21 days.

When violations of normal intestinal microflora in children with atopic dermatitis 5 doses per day courses 20-25 days, with interruptions of 1.5 - 2 months. The number of courses is determined by the state of the skin and the normalization of the intestinal microflora.

If necessary, the doctor appoints repeated courses.

In inflammatory processes of female genitalia, intravaginally administered 5 doses 2 times a day, by irrigation with aqueous suspension of the drug or by the introduction of a tampon impregnated with it. To prevent septic complications, 5 doses are administered once a day for 5-7 days before the proposed operation or delivery.

Side effects:Not identified.

Interaction:

TOlinearly significant interaction of the drug with other drugs is not established. Atzilact can be used simultaneously with antibacterial, antiviral and immunomodulatory therapy. Corrective therapy with acylactone can be prescribed after a course of treatment with specific bacteriophages designed to eliminate conditionally pathogenic bacteria.

Special instructions:The drug does not affect the performance of activities requiring special attention and quick reactions (driving,machinery, etc.).

Form release / dosage:For 5 doses.

Packaging: In the vial; 10 bottles in a pack with instructions for use.

Storage conditions:The drug is stored in accordance with SP 3.3.2.1248-03, at a temperature of 2 to 8 FROM, in a place inaccessible to children.

Transport conditions: transportation is carried out in accordance with SP 3.3.2.1248-03, at a temperature of 2 to 8 FROM.

The drug is not suitable for use:

- at the expiration of the expiry date or during storage with non-observance of the regulated conditions;

- the integrity of the package is broken (cracked bottles);

- without labeling on the vial;

- with changed physical properties (color change, shrinkage of biomass), in the presence of foreign inclusions.

Shelf life:1 year.

Terms of leave from pharmacies:Without recipe

Registration number:P N003279 / 01

Date of registration:01.04.2011 / 06.04.2015

Expiration Date:Unlimited

The owner of the registration certificate:FIRMA FERMENT, LLC FIRMA FERMENT, LLC Russia

Manufacturer: & nbsp

FIRMA FERMENT, LLC Russia

Information update date: & nbsp22.09.2017

Illustrated instructions

Instructions

Atzilact (Acilact)